Quantum-Si Inc. (QSIAW)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
QSIAW Chart
Quantum-Si Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Carmen McClennon WR Wealth Planners, LLC | 66 | $83 | $13.16 | -$69.84 | -84.14% |
Quantum-Si Inc. (QSIAW) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Quantum-Si Inc. ever had a stock split?
Quantum-Si Inc. Profile
| Biotechnology Industry | Healthcare Sector | Jeff Hawkins CEO | NASDAQ (NMS) Exchange | 74765K113 CUSIP |
| US Country | 145 Employees | - Last Dividend | - Last Split | 11 Jun 2021 IPO Date |
Overview
Quantum-Si Incorporated stands out as a pioneering life sciences company, focused on propelling the development of its single-molecule detection platform aimed toward revolutionizing Next Generation Protein Sequencing (NGPS). Since its founding in 2013 and being headquartered in Branford, Connecticut, Quantum-Si has been steadfast in its mission to bring forth innovative solutions within the realm of protein sequencing. Their advanced technology seeks to not only enhance but also simplify the complexities involved in protein identification, affording deeper insights into the diverse functions and structures of proteins in biological systems.
Products and Services
- Platinum NGPS Instrument – This state-of-the-art instrument forms the core of Quantum-Si's platform, offering unparalleled capabilities in protein sequencing. With its cutting-edge technology, the Platinum NGPS instrument allows for the sensitive and accurate analysis of proteins, facilitating a deeper understanding of their structure and function.
- Platinum Analysis Software Service – Accompanying the Platinum NGPS instrument, this software service is designed to process, analyze, and interpret the data generated. It streamlines the workflow of protein sequencing, enabling researchers and scientists to efficiently uncover valuable insights from the data produced by the instrument. The user-friendly interface and comprehensive data analysis tools make it an essential part of Quantum-Si’s offering.
- Reagent Kits and Semiconductor Chips – These are specifically tailored for use with Quantum-Si's instruments. The reagent kits provide the necessary chemicals and materials required for conducting protein sequencing, while the semiconductor chips are designed to facilitate the detection of single molecules. Both are integral to maintaining the high standard of accuracy and sensitivity Quantum-Si's technology promises.
The synergistic application of these products allows for comprehensive applications in various fields, including protein identification, analysis of protein variants, antibody characterization, biomarker identification, and post-translational modification analysis. Quantum-Si's integrated approach not only pushes the boundaries of protein sequencing but also opens new avenues for research and development in life sciences.
